Search Results

You are looking at 1 - 10 of 50 items for :

  • Hashimoto’s thyroiditis x
Clear All
Open access

Guang Ji

References 1 Hashimoto H. Zur Kenntnis der lymphomatöen Veränderung der Schilddrüse (Struma lymphomatosa). Arch F Klin Chir, 1912, 97: 219-48. 2 Drafting group of Guide for Diagnosis and Treatment of Thyroid Diseases in China of Endocrinology Branch of Chinese Medical Association. Guide for Diagnosis and Treatment of Thyroid Diseases in China – Thyroiditis. Chinese Journal of Internal Medicine, 2008, 47 (9): 784-8. 3 Aalberse R C, Stapel S O, Schuurman J, et al . ImmunoglobulinG4: an odd antibody. Clin Exp Allergy, 2009, 39(4):469-77. 4

Open access

Hakki Yilmaz, M. Cakmak, B. Ceydilek, C. Demir and A. Aktas

References Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12, 178-180, 2006. Akinci B, Comlekci A, Yener S, Bayraktar F, Demir T, Ozcan MA, Yuksel F, Yesil S. Hashimoto’s thyroiditis, but not treatment of hypothyroidism, is associated with altered TGFbeta1 levels. Arch Med Res 39, 397-401, 2008. Bettini M

Open access

Julieta B. Gerenova, Irena M. Manolova and Vania I. Tzoneva

gastritis in patients with autoimmune thyroid disease. Arch Intern Med 1999;159:1726-30. 14. Tozzoli R, Kodermaz G, Perosa AR. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a fi ve-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 2010;10:80-3. 15. Gerenova J, Manolova I, Gadjeva V. Hashimoto’s disease - involvement of cytokine network and role of oxidative stress in the severity of Hashimoto’s thyroiditis. In: Springer D. ed. A New Look at Hypothyroidism. Rijeka: InTech; 2012

Open access

Guang Ji

-mediated T-cell infiltration in insulitis. Nat Med, 2002,8(12):1414-1420. 10 Kemp EH, Metcalfe RA, Smith KA, et al . Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf), 2003,59(2):207-213. 11 Kimura H, Kimura M, Rose NR, et al . Early chemokine expression induced by interferon-gamma in a murine model of Hashimoto’s thyroiditis. Exp Mol Pathol, 2004,77(3):161-167. 12 Ubogu EE, Cossoy MB, Ransohoff RM. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci

Open access

Tatjana Zaķe, Sandra Skuja, Aivars Lejnieks, Valērija Groma and Ilze Konrāde

., Schwarz, G., Walfish, P. G., Drummond, V., Usadel, K. H., Bottazzo, G. F. (1990). Susceptibility to thyroid autoimmune disease: Molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto’s thyroiditis. J. Clin. Endocrin. Metab. , 71 (5), 1131–1137. Berger, A. (2000). Th1 and Th2 responses: What are they? BMJ , 321 , 424. Bliddal, S., Borresen, S. W., Feldt-Rasmussen, U. (2017). Thyroid autoimmunity and function after treatment with biological antirheumatic agents in rheumatoid arthritis. Front Endocrinol. , 8 , 179

Open access

Simona Gaberšček and Katja Zaletel

REFERENCES 1. Zaletel K, Gaberšček S. Hashimoto’s thyroiditis: from genes to the disease. Curr Genomics 2011;12:576-88. doi: 10.2174/138920211798120763 2. Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, Pedersen IB, Carlé A. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 2010;24:13-27. doi: 10.1016/j.beem.2009.08.013 3. Zimmermann MB. Iodine requirements and the risks and benefits of correcting iodine deficiency in populations. J Trace Elem Med Biol 2008

Open access

Nikolina Zdraveska and Mirjana Kocova

thyroiditis in apparently healthy school children: epidemiological and clinical study. Endocrinol Jpn. 1975; 22:483-8. 7. Svensson J, Ericsson UB, Nilsson P, Olsson C, Jonsson B, Lindberg B, Ivarsson SA. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J Clin Endocrinol Metab. 2006; 91(5):1729-34 8. Demirbilek H, Kandemir N, Gonc EN, Ozon A et al. Hashimoto’s thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the

Open access

Eugenia Petrova, C. Dumitrache, Andra Buruiana, Maria Olaru, Irina Popescu, Nicoleta Dumitru, M. Ghemigian, B. Petrov and Adina Ghemigian

References 1. Tamer, G., Arik, S., Tamer, I & Coksert, D. (2011). Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid. 21 (8),891-96. DOI:10.1089/THY.2009.0200. 2. Cranney, A., Horsley, T. & O’Donnell, S. (2008). Effectiveness and Safety of Vitamin D in Relation to Bone Health. Evidence Reports/Technology Assessments.158, 543-50; 3. Michael, F.H. (2004). Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J ClinNutr. 6(80), 1678

Open access

Sonja Prćić, Verica Đuran and Dragan Katanić

(Hashimoto’s) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol 2005;53:220-3. 36. Prćić S. Vitiligo i poremećaji funkcije štitaste žlezde kod dece i adolescenata (doktorska disertacija). Novi Sad: Medicinski fakultet Univerziteta u Novom Sadu; 2009. 37. Lio PA. Little white spots: an approach to hypopigmented macules. Arch Dis Child Ed Pract 2008;93:98-102. 38. Parsad D, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatments modalities and their correlation

Open access

Ieva Kalere, Ieva Strēle, Mārtiņš Miglinieks, Ilze Repša, Santa Pildava, Mihails Romanovs, Valdis Pīrāgs and Ilze Konrāde

://www.spkc.gov.lv/lv/statistika-un-petijumi/statistika/veselibas-aprupes-statistika1 (accessed 15.05.2019). Anonymous (2018b). Statistics On Medicines Consumption 2017 . State Agency of Medicines. Available from: https://www.zva.gov.lv/sites/deault/files/inline-files/zva-zstat-2013.pdf (accessed 15.05.2019). Bartalena, L., Bogazzi, F., Chiovato, L., Hubalewska-Dydejczyk, A., Links, T., Vanderpump, M. (2018). 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dys-function. Eur. Thyroid J. , 7 (2), 55–66. Carter, Y., Sippel, R. S., Chen, H. (2013). Hypothyroidism after a